Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
PROG Holdings, Inc stock logo
PRG
PROG
$41.46
-1.8%		$42.28
$25.80
▼
$47.73
$1.68B1.79535,199 shs464,472 shs
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
$25.17
+1.8%		$29.86
$15.51
▼
$34.53
$5.73B1.593.13 million shs1.27 million shs
Upstart Holdings, Inc. stock logo
UPST
Upstart
$29.89
-1.1%		$31.07
$23.97
▼
$76.95
$2.94B2.294.29 million shs3.67 million shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$0.31
-0.9%		$0.48
$0.29
▼
$5.12
$4.41M6.222.44 million shs5.89 million shs
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
PROG Holdings, Inc stock logo
PRG
PROG
-1.00%-7.55%-4.36%+21.90%+35.16%
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
-0.88%-12.27%-26.07%-10.27%+32.90%
Upstart Holdings, Inc. stock logo
UPST
Upstart
-2.83%+2.65%-7.73%+8.51%-56.06%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-1.94%-24.47%-26.46%-56.25%-92.78%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
PROG Holdings, Inc stock logo
PRG
PROG
$41.46
-1.8%		$42.28
$25.80
▼
$47.73
$1.68B1.79535,199 shs464,472 shs
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
$25.17
+1.8%		$29.86
$15.51
▼
$34.53
$5.73B1.593.13 million shs1.27 million shs
Upstart Holdings, Inc. stock logo
UPST
Upstart
$29.89
-1.1%		$31.07
$23.97
▼
$76.95
$2.94B2.294.29 million shs3.67 million shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$0.31
-0.9%		$0.48
$0.29
▼
$5.12
$4.41M6.222.44 million shs5.89 million shs
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
PROG Holdings, Inc stock logo
PRG
PROG
-1.00%-7.55%-4.36%+21.90%+35.16%
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
-0.88%-12.27%-26.07%-10.27%+32.90%
Upstart Holdings, Inc. stock logo
UPST
Upstart
-2.83%+2.65%-7.73%+8.51%-56.06%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-1.94%-24.47%-26.46%-56.25%-92.78%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
PROG Holdings, Inc stock logo
PRG
PROG
2.80
Moderate Buy$49.4419.24% Upside
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
2.92
Moderate Buy$35.2239.94% Upside
Upstart Holdings, Inc. stock logo
UPST
Upstart
2.38
Hold$44.4048.54% Upside
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.25
Hold$2.80789.74% Upside

Current Analyst Ratings Breakdown

Latest UPST, PRG, RSI, and VVOS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/5/2026
Upstart Holdings, Inc. stock logo
UPST
Upstart
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$40.00 ➝ $42.00
8/5/2026
Upstart Holdings, Inc. stock logo
UPST
Upstart
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$43.00
8/5/2026
Upstart Holdings, Inc. stock logo
UPST
Upstart
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$46.00 ➝ $51.00
8/3/2026
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C+) ➝ Buy (B-)
8/3/2026
Upstart Holdings, Inc. stock logo
UPST
Upstart
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
7/30/2026
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$39.00
7/30/2026
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$33.00 ➝ $36.00
7/30/2026
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform
7/30/2026
PROG Holdings, Inc stock logo
PRG
PROG
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
7/30/2026
PROG Holdings, Inc stock logo
PRG
PROG
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$57.00 ➝ $64.00
7/30/2026
PROG Holdings, Inc stock logo
PRG
PROG
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$45.00 ➝ $50.00
(Data available from 8/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
PROG Holdings, Inc stock logo
PRG
PROG
$2.41B0.69$43.64 per share0.95$20.22 per share2.05
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
$1.13B5.14$0.45 per share56.37$1.46 per share17.24
Upstart Holdings, Inc. stock logo
UPST
Upstart
$1.04B2.79$0.80 per share37.47$8.20 per share3.65
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$17.44M0.25N/AN/A($0.16) per share-1.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
PROG Holdings, Inc stock logo
PRG
PROG
$146.79M$3.6211.457.51N/A5.57%21.88%9.15%10/28/2026 (Estimated)
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
$33.31M$0.2986.7940.60N/A2.33%18.88%8.57%N/A
Upstart Holdings, Inc. stock logo
UPST
Upstart
$53.60M$0.4961.0017.580.834.84%7.13%1.82%N/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$21.17M-$2.14N/AN/AN/A-127.70%-2,325.64%-98.12%8/18/2026 (Estimated)

Latest UPST, PRG, RSI, and VVOS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/18/2026Q2 2026
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.42N/AN/AN/A$5.63 millionN/A
8/4/2026Q2 2026
Upstart Holdings, Inc. stock logo
UPST
Upstart
$0.1782$0.16-$0.0182$0.16$354.74 million$364.71 million
7/29/2026Q2 2026
PROG Holdings, Inc stock logo
PRG
PROG
$0.9470$1.19+$0.2430$0.91$713.50 million$719.72 million
7/29/2026Q2 2026
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
$0.1499$0.15+$0.0001$0.10$367.75 million$393.78 million
5/20/2026Q1 2026
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.45-$0.52-$0.07-$0.52$4.35 million$5.14 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
PROG Holdings, Inc stock logo
PRG
PROG
$0.561.35%-44.37%15.47%2 Years
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
N/AN/AN/AN/AN/A
Upstart Holdings, Inc. stock logo
UPST
Upstart
N/AN/AN/AN/AN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/AN/AN/AN/AN/A

Latest UPST, PRG, RSI, and VVOS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/5/2026
PROG Holdings, Inc stock logo
PRG
PROG
quarterly$0.141.22%8/18/20268/18/20269/3/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
PROG Holdings, Inc stock logo
PRG
PROG
1.10
4.03
2.29
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
N/A
2.12
2.12
Upstart Holdings, Inc. stock logo
UPST
Upstart
N/A
0.49
0.49
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/A
0.27
0.27

Institutional Ownership

CompanyInstitutional Ownership
PROG Holdings, Inc stock logo
PRG
PROG
97.92%
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
24.78%
Upstart Holdings, Inc. stock logo
UPST
Upstart
63.01%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
26.35%

Insider Ownership

CompanyInsider Ownership
PROG Holdings, Inc stock logo
PRG
PROG
3.72%
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
52.89%
Upstart Holdings, Inc. stock logo
UPST
Upstart
17.29%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
PROG Holdings, Inc stock logo
PRG
PROG
1,15139.83 million38.35 millionNot Optionable
Rush Street Interactive, Inc. stock logo
RSI
Rush Street Interactive
470231.77 million109.19 millionNot Optionable
Upstart Holdings, Inc. stock logo
UPST
Upstart
1,40597.31 million80.49 millionOptionable
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
16013.90 million13.60 millionOptionable

Recent News About These Companies

Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations
August 11 at 5:17 PM  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/vivos-therapeutics-expands-greenway-health-partnership-to-deploy-ai-enabled-platform-across-all-clinical-and-revenue-operations-1036440833
Vivos Therapeutics Expands AI Workflow Partnership with Greenway Health, Citing Up to $9.1 Million in Annual Value at Sleep Centers of Nevada
August 11 at 8:51 AM  |  quiverquant.comQ
Vivos Therapeutics secures new US patent expanding protection for Vivos CARE technology
August 6, 2026  |  msn.comhttps://www.msn.com/en-us/health/medical/vivos-therapeutics-secures-new-us-patent-expanding-protection-for-vivos-care-technology/ar-AA29snYQ
Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339303/0/en/vivos-therapeutics-announces-issuance-of-new-us-patent-broadening-protection-for-its-vivos-care-oral-medical-device-technology.html
Vivos Therapeutics (VVOS) Stock Fair Value Falls After Analyst Target Cuts
July 18, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/vivos-therapeutics-vvos-stock-fair-170733837.html
Vivos Therapeutics (VVOS) Stock Sees Fair Value Moves Lower As Analysts Reset Growth Assumptions
July 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/vivos-therapeutics-vvos-stock-sees-131707953.html
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
June 30, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/vivos-vida-appliance-shows-statistically-significant-improvement-in-insomnia-severity-in-100-of-study-participants-1036286158
Vivos' Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
June 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/30/3319701/0/en/vivos-vida-appliance-shows-statistically-significant-improvement-in-insomnia-severity-in-100-of-study-participants.html
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
June 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/22/3315285/0/en/vivos-therapeutics-and-streeterville-extend-timeframe-of-strategic-financing-agreement-and-reaffirm-commitment-to-convert-debt-into-common-stock-and-perpetual-preferred-equity.html
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
June 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/11/3310445/0/en/vivos-therapeutics-announces-intent-to-file-a-registration-statement-for-a-proposed-rights-offering.html
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to ...
June 10, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/vivos-therapeutics-announces-key-collaboration-agreement-with-multi-location-florida-cardiology-group-to-extend-much-needed-sleep-apnea-and-insomnia-diagnosis-and-treatment-to-cardiovascular-patients-1036238916
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
June 10, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/10/3309770/0/en/vivos-therapeutics-announces-key-collaboration-agreement-with-multi-location-florida-cardiology-group-to-extend-much-needed-sleep-apnea-and-insomnia-diagnosis-and-treatment-to-card.html
Vivos Therapeutics, Inc. to Present at The Small Cap Showcase & WTR Insights on June 9, 2026
June 8, 2026  |  quiverquant.comQ
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026
June 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/08/3308377/0/en/vivos-therapeutics-to-participate-in-the-small-cap-showcase-wtr-insights-on-june-9-2026.html
Vivos Therapeutics Announces Debt Exchange Agreement with Streeterville Capital to Strengthen Financial Position
June 5, 2026  |  quiverquant.comQ
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing
June 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/05/3307368/0/en/vivos-therapeutics-announces-binding-agreement-for-senior-debt-to-equity-exchange-of-up-to-4-5-million-from-streeterville-capital-to-support-continued-nasdaq-listing.html
Vivos Therapeutics Inc (VVOS) Q1 2026 Earnings Call Highlights: Revenue Surges Amid Strategic Shifts
May 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/vivos-therapeutics-inc-vvos-q1-010200683.html
Vivos Therapeutics Balances Rapid Growth With Cash Strain
May 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/vivos-therapeutics-balances-rapid-growth-with-cash-strain?utm_source=marketbeat.com&utm_medium=referral
Vivos Therapeutics Earnings Call: Growth Meets Cash Strain
May 21, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/vivos-therapeutics-earnings-call-growth-meets-cash-strain?utm_source=marketbeat.com&utm_medium=referral
Vivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
May 21, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68558368-vivos-therapeutics-inc-vivos-therapeutics-reports-first-quarter-2026-financial-results-and-provides-operational-update-399.htm

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
SK Hynix logo displayed on a lit panel inside a semiconductor manufacturing facility with robotic arms and equipment.
The SK Hynix IPO and 2027’s AI Memory Squeeze
By Jeffrey Neal Johnson | July 13, 2026
Micron logo with a silicon wafer, memory modules, and semiconductor chip stack in a lab setting.
Why Micron Is Doubling Down While the HBM Shortage Persists
By Thomas Hughes | July 13, 2026
AMD logo centered on a futuristic circuit-board background with soft blue and red glow accents.
Microsoft's AI Bet Could Rewrite AMD's Growth Story
By Jeffrey Neal Johnson | July 21, 2026
Data center building at dusk with illuminated network light trails and solar panels in the foreground.
The AI Data Center Boom Is Bigger Than One Stock—These ETFs Spread the Bet
By Nathan Reiff | July 17, 2026
Computer monitor displaying a candlestick stock price chart breaking above a resistance line, with traders working in a dark office.
3 Stocks Whose Charts May Be Signaling the Next Big Move
By Dan Schmidt | August 9, 2026
PROG stock logo

PROG NYSE:PRG

$41.46 -0.74 (-1.75%)
Closing price 03:59 PM Eastern
Extended Trading
$41.62 +0.16 (+0.39%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PROG Holdings, Inc. (NYSE:PRG) is a financial technology holding company based in Salt Lake City, Utah with three business segments: Progressive Leasing, which offers lease-to-own transactions primarily to credit-challenged consumers through e-commerce and point-of-sale retail partners, via online, mobile, and in-store solutions; Vive Financial, which provides consumers who may not qualify for traditional prime lending with a variety of second-look, revolving credit products through private label and branded credit cards; and Four Technologies, which provides consumers of all credit backgrounds Buy Now, Pay Later (BNPL) options through four interest-free installments via its platform, Four.

Rush Street Interactive stock logo

Rush Street Interactive NYSE:RSI

$25.17 +0.45 (+1.82%)
Closing price 03:59 PM Eastern
Extended Trading
$25.19 +0.02 (+0.08%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rush Street Interactive, Inc. operates as an online casino and sports betting company in the United States, Canada, Mexico, and rest of Latin America. It provides real-money online casino, online and retail sports betting, and social gaming services. In addition, the company offers full suite of games comprising of bricks-and-mortar casinos, table games, and slot machines. The company markets its online casino and sports betting under BetRivers, PlaySugarHouse, and RushBet brands. Rush Street Interactive, Inc. was founded in 2012 and is headquartered in Chicago, Illinois.

Upstart stock logo

Upstart NASDAQ:UPST

$29.89 -0.32 (-1.06%)
Closing price 04:00 PM Eastern
Extended Trading
$29.92 +0.04 (+0.12%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Upstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small dollar loans that connects consumer demand for loans to its to bank and credit unions. Upstart Holdings, Inc. was founded in 2012 and is headquartered in San Mateo, California.

Vivos Therapeutics stock logo

Vivos Therapeutics NASDAQ:VVOS

$0.31 0.00 (-0.94%)
Closing price 04:00 PM Eastern
Extended Trading
$0.30 -0.01 (-4.35%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas